.... because the rule " Follow the Science as money follows the science" usually applies everywhere and so I hope it will here too. I trust the clinical side, not Hopper. The clinical side can't be replaced easily due to the expert knowledge needed but there are plenty of capable women and men out there who could do Hopper's job.
And I hope to see that change soon before it is too late.
If you think that the sp performances and CRs he's done have contributed to sh being well off then we must look at different screens and read different Hotcopper posts. It is sad when people blindly follow those leaders who aren't able to make the right decisions. If the sp tanks based on unsubstantiated rumours or speculative shorting then we can't blame management. But if the decisions made clearly led to the demise of the financials at all 3 comps then it clearly shows evidence of mismanagement. And I am afraid the upcoming Ts & Cs will confirm that again. But if you enjoy the current scenario then keep on enjoying and supporting the slow death of the CHM and the other 2 comps.
A very, very, scientifically and clinically well progressing company laid down in the financial coffin to be buried, WHY?????????
My attempts to change something were unsuccessful, but at least I tried and won't give up reminding the CEO and the board that there are better ways which could be considered. A dictatorship, regardless where and at what level, is the most efficient way of making decisions and changes. Get them right and all will benefit, get them wrong and disaster strikes. If the current state of CHM isn't a commercial disaster then I don't know what you know about running a successful business. Achieving an "Insolvent" status can't be called " A well done job ". Why else did the ASX and auditors intervene? Because Hopper is business genius? Anyone who is happy here must have studied business in a different universe.
Sorry Dalts, but I don't think you understand the severity of what's unfolding here.
GLTA
CHM Price at posting:
1.4¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)